News
GlobalData on MSN1d
THL Partners to acquire clinical trial site company Headlands Research
The alliance is expected to propel Headlands’ ongoing expansion, with a focus on enhancing its centralised infrastructure.
THL Partners ("THL"), a premier private equity firm investing in middle market growth companies, today announced the entry ...
Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...
Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical trial sites, from KKR in a deal valued at about $600 million, according to ...
THL Partners has agreed to acquire Headlands Research, a Lake Worth, Florida-based network of clinical trial sites, from KKR. No financial terms were disclosed. The transaction is expected to close in ...
THL Partners (www.THL.com) is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and ...
MINNEAPOLIS & BOSTON, February 26, 2024--Agiliti Inc. (NYSE: AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced ...
THL Partners invests in the middle market. Since 1974, THL has raised more than $35 billion of equity capital.
YARDLEY, Pa., October 17, 2024--Red Nucleus ( "the Company"), a leading provider of strategic services across research and development, medical affairs, market access, and learning and development, ...
Private equity firm THL Partners on Monday agreed to acquire a majority stake in AMI, in a deal that people familiar with the matter said valued the provider of semiconductor software at roughly ...
The THL Partners merger agreement had valued CKE at $11.05 per share, or $619 million. [ID:nSGE61P0J7] ...
The deal, which would be THL's first traditional leveraged buyout since it struck an $18 billion agreement to buy Clear Channel Communications in 2008, values CKE at $11.05 per share, a premium of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback